주메뉴 바로가기 본문내용 바로가기 사이트정보 바로가기

월례회/워크숍/학술대회

제목 - 설명
  • [월례세미나] 2022-09 IIBS Seminar 임승외 교수 – Purdue University (9월 27일)

    • 등록일
      2022.09.02
    • 조회수
      521
  • 첨부파일

2022학년도 2학기 기초과학융합연구소 월례세미나를 안내해 드립니다.

 

•연사: 임승외 교수 (Purdue University)

 

•제목: Development and Preclinical Evaluation of Immuno-Oncology Drugs

 

•일시: 9월 27일 화요일 오후 3시

 

•장소: 베어드홀 513호

 

•초록: Immunotherapy, a rapidly evolving area in the field of oncology, is a treatment option that relies on and utilizes the body’s immune system to combat cancer. Ranging from immune checkpoint blockade therapies to vaccines and T-cell transfer therapies, immunotherapy has demonstrated great clinical promise and potential since its development. However, clinical and pre-clinical studies have shown that immunotherapy is only successful in a minority of patients and highly depends on the tumor microenvironment. Therefore, new immunotherapeutic strategies to improve the therapeutic efficacy of current immunotherapy are urgently needed. To improve immune checkpoint blockade-based therapies, relevant pre-clinical animal models are an essential component in the development and testing of multiple combination approaches and strategies. In the current seminar, I will introduce how we develop immunotherapeutic antibodies and validate their therapeutic efficacy in both in vitro and in vivo.

 

많은 참여를 부탁드립니다.

기초과학융합연구소

상단으로 이동